Korro Bio, Inc. Construction in Progress, Gross
Korro Bio, Inc. (KRRO) had Construction in Progress, Gross of $18.30 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:ConstructionInProgressGross · last filed 2024-08-13
- 2024-06-30: Construction in Progress, Gross $18.30M.
- 2024-03-31: Construction in Progress, Gross $13.40M.
- 2023-12-31: Construction in Progress, Gross $8.20M.
- 2022-12-31: Construction in Progress, Gross $2.00M.
| Period end | Construction in Progress, Gross |
|---|---|
| 2024-06-30 | $18.30M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $13.40M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $8.20M 10-Q · filed 2024-08-13 |
| 2022-12-31 | $2.00M 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |